Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 274

    1.

    Low IGF-I and elevated testosterone during puberty in subjects with type 1 diabetes developing microalbuminuria in comparison to normoalbuminuric control subjects: the Oxford Regional Prospective Study.

    Amin R, Schultz C, Ong K, Frystyk J, Dalton RN, Perry L, Ørskov H, Dunger DB; Oxford Regional Prospective Study.

    Diabetes Care. 2003 May;26(5):1456-61.PMID: 12716804 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Microalbuminuria prevalence varies with age, sex, and puberty in children with type 1 diabetes followed from diagnosis in a longitudinal study. Oxford Regional Prospective Study Group.

    Schultz CJ, Konopelska-Bahu T, Dalton RN, Carroll TA, Stratton I, Gale EA, Neil A, Dunger DB.

    Diabetes Care. 1999 Mar;22(3):495-502.PMID: 10097935 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Increasing urine albumin excretion is associated with growth hormone hypersecretion and reduced clearance of insulin in adolescents and young adults with type 1 diabetes: the Oxford Regional Prospective Study.

    Amin R, Williams RM, Frystyk J, Umpleby M, Matthews D, Orskov H, Dalton RN, Dunger DB.

    Clin Endocrinol (Oxf). 2005 Feb;62(2):137-44.PMID: 15670188 [PubMed - indexed for MEDLINE]Related articles

    4.

    The relationship between microalbuminuria and glomerular filtration rate in young type 1 diabetic subjects: The Oxford Regional Prospective Study.

    Amin R, Turner C, van Aken S, Bahu TK, Watts A, Lindsell DR, Dalton RN, Dunger DB.

    Kidney Int. 2005 Oct;68(4):1740-9.PMID: 16164650 [PubMed - indexed for MEDLINE]Related articles

    8.

    Blood pressure does not rise before the onset of microalbuminuria in children followed from diagnosis of type 1 diabetes. Oxford Regional Prospective Study Group.

    Schultz CJ, Neil HA, Dalton RN, Konopelska Bahu T, Dunger DB; Oxford Regional Prospective Study Group.

    Diabetes Care. 2001 Mar;24(3):555-60.PMID: 11289484 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Discontinuation of estrogen replacement therapy in GH-treated hypopituitary women alters androgen status and IGF-I.

    Christiansen JJ, Fisker S, Gravholt CH, Bennett P, Svenstrup B, Andersen M, Feldt-Rasmussen U, Christiansen JS, Jørgensen JO.

    Eur J Endocrinol. 2005 May;152(5):719-26.PMID: 15879357 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Alterations in growth hormone secretion and clearance in adolescent boys with insulin-dependent diabetes mellitus.

    Nieves-Rivera F, Rogol AD, Veldhuis JD, Branscom DK, Martha PM Jr, Clarke WL.

    J Clin Endocrinol Metab. 1993 Sep;77(3):638-43.PMID: 8370685 [PubMed - indexed for MEDLINE]Related articles

    11.

    Risk of nephropathy can be detected before the onset of microalbuminuria during the early years after diagnosis of type 1 diabetes.

    Schultz CJ, Neil HA, Dalton RN, Dunger DB; Oxforn Regional Prospective Study Group.

    Diabetes Care. 2000 Dec;23(12):1811-5.PMID: 11128358 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Pubertal growth in IDDM is determined by HbA1c levels, sex, and bone age.

    Ahmed ML, Connors MH, Drayer NM, Jones JS, Dunger DB.

    Diabetes Care. 1998 May;21(5):831-5. Erratum in: Diabetes Care 1998 Aug;21(8):1382. PMID: 9589250 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Prevalence and risk factors of microalbuminuria in a cohort of African-American women with gestational diabetes.

    Go RC, Desmond R, Roseman JM, Bell DS, Vanichanan C, Acton RT.

    Diabetes Care. 2001 Oct;24(10):1764-9.PMID: 11574439 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem?

    Halldin MU, Tylleskär K, Hagenäs L, Tuvemo T, Gustafsson J.

    Clin Endocrinol (Oxf). 1998 Jun;48(6):785-94.PMID: 9713569 [PubMed - indexed for MEDLINE]Related articles

    16.

    Serum prostate specific antigen, sex hormone binding globulin and free androgen index as markers of pubertal development in boys.

    Kim MR, Gupta MK, Travers SH, Rogers DG, Van Lente F, Faiman C.

    Clin Endocrinol (Oxf). 1999 Feb;50(2):203-10.PMID: 10396363 [PubMed - indexed for MEDLINE]Related articles

    17.

    C-reactive protein in relation to the development of microalbuminuria in type 1 diabetes: the Oxford Regional Prospective Study.

    Marcovecchio ML, Giannini C, Widmer B, Dalton RN, Martinotti S, Chiarelli F, Dunger DB.

    Diabetes Care. 2008 May;31(5):974-6. Epub 2008 Jan 30.PMID: 18235049 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    A longitudinal study of the effects of a gluten-free diet on glycemic control and weight gain in subjects with type 1 diabetes and celiac disease.

    Amin R, Murphy N, Edge J, Ahmed ML, Acerini CL, Dunger DB.

    Diabetes Care. 2002 Jul;25(7):1117-22.PMID: 12087007 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Steroids in adult men with type 1 diabetes: a tendency to hypogonadism.

    van Dam EW, Dekker JM, Lentjes EG, Romijn FP, Smulders YM, Post WJ, Romijn JA, Krans HM.

    Diabetes Care. 2003 Jun;26(6):1812-8.PMID: 12766115 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    An IGF-I gene polymorphism modifies the risk of developing persistent microalbuminuria in type 1 diabetes.

    Hovind P, Lamberts S, Hop W, Deinum J, Tarnow L, Parving HH, Janssen JA.

    Eur J Endocrinol. 2007 Jan;156(1):83-90.PMID: 17218729 [PubMed - indexed for MEDLINE]Related articlesFree article